|
|
Gene Symbol |
NFKB1 |
|
Aliases |
CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 |
|
Entrez Gene ID |
|
|
Gene Name |
Nuclear factor kappa B subunit 1 |
|
Chromosomal Location |
4q24 |
|
HGNC ID |
|
|
Summary |
This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Feb 2016]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
IC |
16938301 |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
IGI |
24434150 |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
IMP |
19881551 |
GO:0006366 |
Biological process |
Transcription by RNA polymerase II |
TAS |
1992489 |
GO:0006954 |
Biological process |
Inflammatory response |
TAS |
1992489 |
GO:0010629 |
Biological process |
Negative regulation of gene expression |
IDA |
26687115 |
GO:0010744 |
Biological process |
Positive regulation of macrophage derived foam cell differentiation |
IC |
16938301 |
GO:0010884 |
Biological process |
Positive regulation of lipid storage |
IC |
16938301 |
GO:0010956 |
Biological process |
Negative regulation of calcidiol 1-monooxygenase activity |
IDA |
15243130 |
GO:0010957 |
Biological process |
Negative regulation of vitamin D biosynthetic process |
IC |
15243130 |
GO:0032269 |
Biological process |
Negative regulation of cellular protein metabolic process |
IC |
16938301 |
GO:0032375 |
Biological process |
Negative regulation of cholesterol transport |
IC |
16938301 |
GO:0043066 |
Biological process |
Negative regulation of apoptotic process |
TAS |
10811897 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
17426251 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IMP |
20018240 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
NAS |
8096091 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
1406630 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IMP |
19955433 |
GO:0071222 |
Biological process |
Cellular response to lipopolysaccharide |
IMP |
23776175 |
GO:0071260 |
Biological process |
Cellular response to mechanical stimulus |
IEP |
19593445 |
GO:0071316 |
Biological process |
Cellular response to nicotine |
IMP |
22357537 |
GO:0071347 |
Biological process |
Cellular response to interleukin-1 |
IEP |
12958148 |
GO:0071354 |
Biological process |
Cellular response to interleukin-6 |
IMP |
22357537 |
GO:0090263 |
Biological process |
Positive regulation of canonical Wnt signaling pathway |
IMP |
20018240 |
GO:1900127 |
Biological process |
Positive regulation of hyaluronan biosynthetic process |
IDA |
17324121 |
GO:1904385 |
Biological process |
Cellular response to angiotensin |
IMP |
22357537 |
GO:2000630 |
Biological process |
Positive regulation of miRNA metabolic process |
IMP |
22357537 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
11819787, 16938301, 25411248 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
11819787 |
GO:0033256 |
Cellular component |
I-kappaB/NF-kappaB complex |
TAS |
16938301 |
GO:0000976 |
Molecular function |
Transcription regulatory region sequence-specific DNA binding |
IDA |
18718911 |
GO:0000977 |
Molecular function |
RNA polymerase II regulatory region sequence-specific DNA binding |
IDA |
7959007 |
GO:0000980 |
Molecular function |
RNA polymerase II distal enhancer sequence-specific DNA binding |
IDA |
1406630 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISM |
19274049 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
NAS |
19274049 |
GO:0001227 |
Molecular function |
DNA-binding transcription repressor activity, RNA polymerase II-specific |
IDA |
24434510 |
GO:0001228 |
Molecular function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IDA |
1406630 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IDA |
17426251 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
8196632, 8441377, 9865693, 10023675, 10498867, 11297557, 11526476, 11931769, 12482991, 12832462, 14624448, 14743216, 15799966, 16108830, 16306601, 16319921, 17003112, 18045535, 19358846, 20195357, 20237821, 20547752, 21483817, 21988832, 23636254, 25241761, 25609649, 25852190, 264966 |
GO:0008134 |
Molecular function |
Transcription factor binding |
IDA |
18270204 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
12482991, 12832462, 21988832, 25609649 |
GO:0042805 |
Molecular function |
Actinin binding |
IPI |
25411248 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IDA |
16938301, 17426251 |
GO:0046982 |
Molecular function |
Protein heterodimerization activity |
IDA |
7959007, 18212740 |
|
Protein Information |
|
Protein Name |
Nuclear factor NF-kappa-B p105 subunit, DNA-binding factor KBF1, NF-kappabeta, nuclear factor NF-kappa-B p50 subunit, nuclear factor kappa-B DNA binding subunit, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
Function |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000418009 |
|
|
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Hyperoxaluria |
|
Digestive System Diseases |
Biliary Cirrhosis |
|
Liver Diseases |
|
Colitis |
|
Cholangitis |
|
Crohn Disease |
|
Ear Or Mastoid Diseases |
Meniere Disease |
|
Endocrine System Diseases |
Diabetes Mellitus |
|
PCOS |
|
Immune System Diseases |
Immunodeficiency |
|
Musculoskeletal Diseases |
Spondylitis |
|
Neoplasms |
Adenocarcinoma |
|
Carcinoma |
|
Colonic Neoplasms |
|
Ovarian Cysts |
|
Corpus Luteum Cyst |
|
Cribriform Carcinoma |
|
Nervous System Diseases |
Cerebral Ischemia |
|
Psychiatric/Brain disorders |
Mood Disorders |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Kidney Failure |
|
Kidney Insufficiency |
|
Oxalosis |
|
Reproductive disorders |
Preeclampsia |
|
Skin and Connective Tissue Diseases |
Psoriasis |
|
|
References |
|
|
Li Da, You Yue, Bi Fang-Fang, Zhang Tie-Ning, Jiao Jiao, Wang Tian-Ren, Zhou Yi-Ming, Shen Zi-Qi, Wang Xiu-Xia, Yang Qing |
Center of Reproductive MedicineShengjing Hospital of China Medical University, Shenyang, China.| Department of Obstetrics and GynecologyShengjing Hospital of China Medical University, Shenyang, China.| Department of Obstetrics and GynecologyShengjing Hospital of China Medical University, Shenyang, China.| Department of PediatricsShengjing Hospital of China Medical University, Shenyang, China.| Center of Reproductive MedicineShengjing Hospital of China Medical University, Shenyang, China.| Center of Reproductive MedicineShengjing Hospital of China Medical University, Shenyang, China.| Department of ObstetricsGynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.| Department of MedicineBrigham and Women's Hospital, Harvard Institutes of Medicine, Harvard Medical School, Boston, Massachusetts, USA.| Center of Reproductive MedicineShengjing Hospital of China Medical University, Shenyang, China.| Center of Reproductive MedicineShengjing Hospital of China Medical University, Shenyang, China yangq@sj-hospital.org wangxxsj@sina.cn.| Department of Obstetrics and GynecologyShengjing Hospital of China Medical University, Shenyang, China yangq@sj-hospital.org wangxxsj@sina.cn. |
Reproduction. 2018 Jan;155(1):85-92. doi: 10.1530/REP-17-0499. Epub 2017 Oct 13. |
Abstract
The importance of autophagy in polycystic ovary syndrome (PCOS)-related metabolic disorders is increasingly being recognized, but few studies have investigated the role of autophagy in PCOS. Here, transmission electron microscopy demonstrated that autophagy was enhanced in the ovarian tissue from both humans and rats with PCOS. Consistent with this, ovarian granulosa cells from PCOS rats showed increases in the autophagy marker protein light chain 3B (LC3B), whereas levels of the autophagy substrate SQSTM1/p62 were decreased. In addition, the ratio of LC3-II/LC3-I was markedly elevated in human PCOS ovarian tissue compared with normal ovarian tissue. Real-time PCR arrays indicated that 7 and 34 autophagy-related genes were down- and up-regulated in human PCOS , Signal-Net, and regression analysis suggested that there are a wide range of interactions among these 41 genes, and a potential network based on EGFR, ERBB2, FOXO1, MAPK1, NFKB1, IGF1,TP53 and MAPK9 may be responsible for autophagy activation in PCOS. Systematic functional analysis of 41 differential autophagy-related genes indicated that these genes are highly involved in specific cellular processes such as response to stress and stimulus, and are linked to four significant pathways, including the insulin, ERBB, mTOR signaling pathways and protein processing in the endoplasmic reticulum. This study provides evidence for a potential role of autophagy disorders in PCOS in which autophagy may be an important molecular event in the pathogenesis of PCOS. |
|
|
Lu Jiayin, Wang Zixu, Cao Jing, Chen Yaoxing, Dong Yulan |
Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China. yxchen@cau.edu.cn.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China. ylbcdong@cau.edu.cn. |
Reprod Biol Endocrinol. 2018 Aug 20;16(1):80. doi: 10.1186/s12958-018-0391-5. |
Abstract
In recent years, the study of oxidative stress (OS) has become increasingly popular. In particular, the role of OS on female fertility is very important and has been focused on closely. The occurrence of OS is due to the excessive production of reactive oxygen species (ROS). ROS are a double-edged sword; they not only play an important role as secondary messengers in many intracellular signaling cascades, but they also exert indispensable effects on pathological processes involving the female genital tract. ROS and antioxidants join in the regulation of reproductive processes in both animals and humans. Imbalances between pro-oxidants and antioxidants could lead to a number of female reproductive diseases. This review focuses on the mechanism of OS and a series of female reproductive processes, explaining the role of OS in female reproduction and female reproductive diseases caused by OS, including polycystic ovary syndrome (PCOS), endometriosis, preeclampsia and so on. Many signaling pathways involved in female reproduction, including the Keap1-Nrf2, NF-kappaB, FOXO and MAPK pathways, which are affected by OS, are described, providing new ideas for the mechanism of reproductive diseases. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|